David Burns
Gastroenterology · Peekskill, NYNPI 1548265481
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 356 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 36 manufacturers reported payments, led by AbbVie at 32.5% of the total. Reporting peaked in 2022 at $2,952 and has fallen 99.0% since, to $29 in 2024.
Across 356 payments — averaging $24.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Novo Nordisk$992
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$600
- Abbott$440
- Bayer$358
- Janssen Scientific Affairs, LLC$329
- plus $3K from 30 others
What the payments were for
- Food & beverage$8,632100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 117 | $2,802 |
| Novo Nordisk | 55 | $992 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 27 | $600 |
| Abbott | 9 | $440 |
| Bayer | 15 | $358 |
| Janssen Scientific Affairs, LLC | 3 | $329 |
| GSK | 12 | $328 |
| Lilly USA, LLC | 15 | $298 |
| Arbor Pharmaceuticals, Inc. | 20 | $282 |
| Amarin Pharma, Inc. | 8 | $269 |
| Johnson & Johnson | 6 | $250 |
| Grifols USA, LLC | 6 | $224 |
| AstraZeneca | 8 | $211 |
| Almirall LLC | 4 | $174 |
| Nestle Healthcare Nutrition Inc. | 1 | $125 |
| Lundbeck LLC | 6 | $118 |
| Boehringer Ingelheim | 6 | $117 |
| Pfizer | 5 | $98 |
| Avanir Pharmaceuticals, Inc. | 4 | $87 |
| Idorsia Pharmaceuticals US Inc | 4 | $78 |
| Kowa Pharmaceuticals America, Inc. | 4 | $73 |
| Novartis | 4 | $65 |
| Amgen | 3 | $52 |
| Endo Pharmaceuticals Inc. | 2 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Exact Sciences | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Genentech USA, Inc. | 1 | $20 |
| Merz North America, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Circassia Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Ardelyx, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,632 in reported general payments places this provider in the 75th percentile of 1,682 gastroenterology providers in New York.
Other gastroenterology in Peekskill
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Maya SrivastavaWilliamsville$1.8M
- Melissa PalmerPlainview$1M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.